Tagrix 80mg (Osimertinib) What is Beacon?

Tagrix 80mg (Osimertinib) What is Beacon?

Blog Article

Tagrix 80mg contains the main active ingredient Osimertinib mesylate, available in tablet form, which is indicated for use mainly in the targeted treatment of non-small cell lung cancer. The drug Tagrix 80mg (Osimertinib) Beacon has been tested and used in many countries, including Vietnam.

Basic information
Active ingredient: Osimertinib mesylate.

Drug class: Anticancer drugs, protein kinase inhibitors.
Trade name: Tagrix 80 Mg (Osimertinib)
Dosage form: Tablets.

Packaging: Box of 30 tablets.
Origin: Bangladesh.

Ingredients
Osimertinib mesylate - 80mg
Excipients 1 capsule.
What should be avoided when taking Tagrix 80mg?

When taking the drug, in addition to using it as prescribed by the treating doctor, it is necessary to limit the use of processed foods with a lot of fat and preservatives, in addition, pay attention to abstain from the use of carbonated food drinks, containing alcohol. Alcohol, stimulants such as alcohol, beer, cigarettes, etc.

Preserve
Store at a temperature not exceeding 30°C.
Avoid sunlight.

Keep out of reach of children.
Substitute of Tagrix

Osimertinib (Tagrix) is the 1st and only drug of its kind approved by USFDA for the treatment of epidermal growth factor receptor (EGFR) positive Non- Small Cell Lung Cancer (NSCLC) patients with T790M mutation.

 

Phone: +8801933042721
Email: iebpharma108@gmail.com
Sector 3, Road 8, Uttara-1230 Dhaka, Bangladesh
website: https://iebpharma.com